These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 35407416)
21. [Comparison and analysis of minimal residual disease in multiple myeloma patients detected by 4-color and 8-color fluorescence antibody panels]. Wang YZ; Lu J; Hao L; Chang Y; He LL; Huang XJ; Liu YR Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):272-278. PubMed ID: 28468086 [No Abstract] [Full Text] [Related]
22. Impact of CD138 Magnetic Bead-based Positive Selection on Bone Marrow Plasma Cell Surface Markers. Bansal R; Kimlinger T; Gyotoku KA; Smith M; Rajkumar V; Kumar S Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e48-e51. PubMed ID: 32873534 [TBL] [Abstract][Full Text] [Related]
23. [Recent advances on the prognostic value of immunophenotyping in multiple myeloma by flow cytometry]. Guo J; Chang CK; Su JY; Zhang X; Li X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1178-82. PubMed ID: 25130852 [TBL] [Abstract][Full Text] [Related]
24. Accuracy of Bone Marrow Flow Cytometry Analysis in Patients With Plasma Cell Neoplasm in Thailand: A Single Institutional Study. Limvorapitak W; Srisum-Ang T; Chimres C; Warnnissorn N; Kanitsap N Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e27-37. PubMed ID: 26796980 [TBL] [Abstract][Full Text] [Related]
25. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients. Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900 [TBL] [Abstract][Full Text] [Related]
26. [Immunophenotype characteristics in multiple myeloma cells and their significance]. Sun Y; Fang MY; Liu YJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):381-4. PubMed ID: 20416173 [TBL] [Abstract][Full Text] [Related]
27. Immunophenotype and DNA cell content in multiple myeloma. San Miguel JF; Garcia-Sanz R; Gonzalez M; Orfao A Baillieres Clin Haematol; 1995 Dec; 8(4):735-59. PubMed ID: 8845570 [TBL] [Abstract][Full Text] [Related]
29. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Pellat-Deceunynck C; Barillé S; Puthier D; Rapp MJ; Harousseau JL; Bataille R; Amiot M Cancer Res; 1995 Aug; 55(16):3647-53. PubMed ID: 7543019 [TBL] [Abstract][Full Text] [Related]
30. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma. Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877 [TBL] [Abstract][Full Text] [Related]
31. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Lin P; Owens R; Tricot G; Wilson CS Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299 [TBL] [Abstract][Full Text] [Related]
32. Analysis of bone marrow plasma cells in patients with solitary bone plasmacytoma. Bhaskar A; Gupta R; Sharma A; Kumar L; Jain P Cancer Ther; 2009; 7():49-52. PubMed ID: 26834513 [TBL] [Abstract][Full Text] [Related]
33. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates. Post SR; Post GR; Nikolic D; Owens R; Insuasti-Beltran G Cytometry B Clin Cytom; 2018 Sep; 94(5):602-610. PubMed ID: 29573142 [TBL] [Abstract][Full Text] [Related]
34. Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry. Alaterre E; Raimbault S; Garcia JM; Rème T; Requirand G; Klein B; Moreaux J Cytometry B Clin Cytom; 2018 May; 94(3):484-492. PubMed ID: 28865180 [TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070 [TBL] [Abstract][Full Text] [Related]
36. Immunophenotypic Heterogeneity of Polytypic Plasma Cells and the Impact on Myeloma Minimal Residual Disease Detection by Multiparameter Flow Cytometry. Schouweiler KE; Karandikar NJ; Holman CJ Cytometry B Clin Cytom; 2019 Jul; 96(4):310-318. PubMed ID: 31140731 [TBL] [Abstract][Full Text] [Related]
37. [Correlation of CD19 positive cell counts in bone marrow with therapeutic efficacy in patients with multiple myeloma]. Zhang L; Zhou ZH; Li XY; Ouyang J; Su C; Li J; Luo SK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):64-7. PubMed ID: 21362223 [TBL] [Abstract][Full Text] [Related]
38. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis. McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810 [TBL] [Abstract][Full Text] [Related]
39. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis. Martín P; Santón A; Bellas C Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904 [TBL] [Abstract][Full Text] [Related]
40. [Immunophenotype characteristics of patients with multiple myeloma in different risk stratification]. Hu K; Wang J; Zhu MX; Wang YF; Ke XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1624-7. PubMed ID: 25543486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]